Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Lyell Immunopharma Inc | LYEL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.20 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 1.32 - 3.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 2.20 | USD |
Lyell Immunopharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
559.01M | 254.10M | - | 2.92M | -234.63M | -0.92 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Lyell Immunopharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LYEL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.31 | 2.55 | 2.15 | 2.32 | 805,923 | -0.11 | -4.76% |
1 Month | 2.27 | 3.145 | 2.015 | 2.44 | 987,727 | -0.07 | -3.08% |
3 Months | 1.82 | 3.2556 | 1.69 | 2.30 | 919,748 | 0.38 | 20.88% |
6 Months | 1.58 | 3.2556 | 1.52 | 2.10 | 1,128,074 | 0.62 | 39.24% |
1 Year | 1.91 | 3.97 | 1.32 | 2.31 | 1,021,356 | 0.29 | 15.18% |
3 Years | 18.75 | 19.84 | 1.32 | 4.81 | 941,057 | -16.55 | -88.27% |
5 Years | 18.75 | 19.84 | 1.32 | 4.81 | 941,057 | -16.55 | -88.27% |
Lyell Immunopharma Description
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors). |